Advanced search
Publication Cover
Leukemia & Lymphoma Volume 55, 2014 - Issue 7
Submit an article Journal homepage
883
Views
11
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Bortezomib in combination with thalidomide or lenalidomide or doxorubicin regimens for the treatment of multiple myeloma: a meta-analysis of 14 randomized controlled trials

Long WangDepartment of Hematology, Nanjing Hospital Affiliated Nanjing Medical University, Nanjing, China
,
Yan-Li XuDepartment of Hematology, Nanjing Hospital Affiliated Nanjing Medical University, Nanjing, ChinaCorrespondence[email protected]
&
Xiu-Qun ZhangDepartment of Hematology, Nanjing Hospital Affiliated Nanjing Medical University, Nanjing, China
Pages 1479-1488 | Received 05 Jun 2013, Accepted 19 Aug 2013, Published online: 24 Feb 2014

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Wilson I. Gonsalves & Morie A. Gertz. (2014) Bortezomib-based combination regimens in myeloma: more is not necessarily better. Leukemia & Lymphoma 55:7, pages 1439-1440.
Read now

Articles from other publishers (10)

Tiffany Li, Hannah C. Timmins, Hillard M. Lazarus & Susanna B. Park. (2020) Peripheral neuropathy in hematologic malignancies – Past, present and future. Blood Reviews 43, pages 100653.
Crossref
Tiffany Li, Hannah C. Timmins, Tracy King, Matthew C. Kiernan, David Goldstein & Susanna B. Park. (2020) Characteristics and risk factors of bortezomib induced peripheral neuropathy: A systematic review of phase III trials. Hematological Oncology 38:3, pages 229-243.
Crossref
Rongxin Yao, Xudong Hu, Shuping Zhou, Qianying Zhang, He Huang, Ni Sun, Wenjian Guo, Kang Yu & Ying Lin. (2019) Once-weekly bortezomib had similar effectiveness and lower thrombocytopenia occurrence compared with twice-weekly bortezomib regimen in treating patients with newly diagnosed multiple myeloma in China. Medicine 98:39, pages e17147.
Crossref
Alexandre Detappe, Mark Bustoros, Tarek H. Mouhieddine & P. Peter Ghoroghchian. (2018) Advancements in Nanomedicine for Multiple Myeloma. Trends in Molecular Medicine 24:6, pages 560-574.
Crossref
De-Dong Cao, Hui-Lin Xu, Liang Liu, Yong-Fa Zheng, Si-Fa Gao, Xi-Ming Xu & Wei Ge. (2017) Thalidomide combined with transcatheter artierial chemoembolzation for primary hepatocellular carcinoma: a systematic review and meta-analysis. Oncotarget 8:27, pages 44976-44993.
Crossref
Patricia Melo Aguiar, Tácio de Mendonça Lima, Gisele Wally Braga Colleoni & Sílvia Storpirtis. (2017) Efficacy and safety of bortezomib, thalidomide, and lenalidomide in multiple myeloma: An overview of systematic reviews with meta-analyses. Critical Reviews in Oncology/Hematology 113, pages 195-212.
Crossref
Jiliang Xia, Hongwei Xu, Xiaoyan Zhang, Chantal Allamargot, Kristen L. Coleman, Randy Nessler, Ivana Frech, Guido Tricot & Fenghuang Zhan. (2017) Multiple Myeloma Tumor Cells are Selectively Killed by Pharmacologically-dosed Ascorbic Acid. EBioMedicine 18, pages 41-49.
Crossref
Thomas J. Anastasio. (2015) Computational identification of potential multi-drug combinations for reduction of microglial inflammation in Alzheimer disease. Frontiers in Pharmacology 6.
Crossref
Noah Merin & Kevin Kelly. (2014) Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma. Pharmaceuticals 8:1, pages 1-20.
Crossref
Katja Weisel & Lothar Kanz. 2014. Small Molecules in Oncology. Small Molecules in Oncology 347 357 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.